A B S T R A C T The effects of estrogen and progesterone on uterine alpha-adrenergic receptors were investigated by direct receptor-binding studies. Immature female rabbits were primed with estrogen by intramuscular injections for 4 days. Other rabbits were primed with progesterone by injections of estrogen for 4 days followed by injections of progesterone for 4 days. The alpha adrenergic antagonist, [3H]dihydroergocryptine, was used to directly assess the number and affinity of alpha adrenergic receptors in membranes derived from estrogen-and progesterone-primed uteri. Membranes from estrogen-primed uteri contained 257+52 fmol of [3H ]dihydroergocryptine-binding sites per mg protein whereas membranes from progesterone-primed uteri contained 83+11 fmol of binding sites per mg protein. This reduction of alpha adrenergic receptor-binding sites by progesterone was statistically significant (P < 0.02). In contrast, no significant difference in the binding site affinity was observed between the estrogen-and progesterone-primed groups. The progesterone-induced decrease in the number of uterine alpha adrenergic receptors provides a potential explanation for the reduced alpha adrenergic contractile response to epinephrine in the progesterone-primed myometrium.
INTRODUCTION
Regulation of the contractile state of the uterus is achieved by modification of endocrine, autonomic, and mechanical factors during adolescence, the menstrual cycle, normal pregnancy, premature labor, and parturition. One well-documented mechanism by which uterine contraction can be initiated is by catecholamineinduced stimulation of myometrial alpha adrenergic Dr. Lefkowitz is an Investigator of the Howard Hughes Medical Institute. Received for publication 31 January 1977 and in revised form 27 May 1977. receptors (1) (2) (3) (4) . In contrast, inhibition of uterine activity can be induced by catecholamine stimulation of beta adrenergic receptors. Thus endogenous catecholamines can theoretically cause either excitation or inhibition of the uterus depending on whether alpha or beta adrenergic receptors predominate. The adrenergic responsiveness of the myometrium appears to be regulated by steroid hormones. Thus, when the uterus is predominantly under the influence of estrogen, an alpha adrenergic contractile response is elicitied by administered catecholamines or by sympathetic nerve stimulation. By contrast when estrogen-primed uteri are subsequently placed under the influence ofprogesterone, the alpha adrenergic contractile response is diminished significantly (5, 6) . One possible mechanism by which progesterone might cause a decrease in alpha adrenergic responsiveness of the myometrium would be by a decrease in the number of functional alpha adrenergic receptors caused by a direct effect ofprogesterone on the myometrium. Thus, in the estrogen-primed uterus (in the absence of progesterone), alpha adrenergic receptors would be high in number and the myometrial response to catecholamines would be contraction, whereas under the influence of progesterone, the number of alpha adrenergic receptors would be reduced allowing the unmasking of the beta adrenergic inhibitor effect of the catecholamines on the myometrium.
Recently, techniques have been developed (7) for directly assessing the number and affinity of uterine alpha adrenergic receptors by radioligand-binding studies using the radioactively labeled alpha adrenergic antagonist [3H]dihydroergocryptine. In the present investigation we utilized these binding technqiues to study the effects of estrogen and progesterone treatment on the number and affinity ofuterine alpha adrenergic receptors. The results show that estrogen-primed uteri have a significantly higher number ofalpha adrenergic receptors than progesterone-primed uteri. Progesterone-primed rabbits. Rabbits were injected by a schedule indentical to progesterone-primed rabbits of protocol I.
On the 9th day all rabbits were sacrificed by air embolization and the uteri were immediately removed and used. Uteri were cleaned of fat, scraped of endometrium and homogenized in ice-cold buffer (0.25 M sucrose, 1 mM MgCl2, 5 mM Tris-HCl, pH 7.5) as previously described (8) . The homogenate was centrifuged at 300 g for 10 min to remove cellular debris. The supemate was then centrifuged at 28,000 g for 10 min. The final pellet was resuspended in buffer and used in the binding assay.
[3H]Dihydroergocryptine ([3H]DHE)' binding was assayed as previously described (8, 9) by incubating uterine membranes (4-9 mg/ml) with [3H]DHE present at concentrations between 5 and 60 nM in 150 Al of buffer containing 15 mM MgCl2 and 50 mM Tris-HCl (pH 7.5) at 25°C for 17 min. The incubation was terminated as previously described (8) by diluting a 125-,ul incubation aliquot into 2 ml of incubation buffer (25°C) followed by rapid filtration through Whatman GFC glass fiber filters. The filters were immediately washed with 20 ml of incubation buffer (25°C) and then dried. The radioactivity on each filter was measured by liquid scintillation spectrophotometry at an efficiency of40%. "Nonspecific" binding is defined as binding which is not displaced by a high concentration (10 ,M) of phentolamine, a potent alphaadrenergic antagonist which should occupy essentially all of the alpha adrenergic-binding sites. "Specific" or receptor binding is defined as total radioactivity bound minus nonspecific binding, and was generally 50-90% ofthe total counts bound to membrane protein, the percentage varying inversely with the concentration of [3H]DHE utilized. " [3H]DHE binding" in the figure refers to specific binding as defined above. Protein was determined by the method of Lowry et al. (10) . Adenylate cyclase activity was measured as previously described (11).
[3H]DHE was prepared by New England Nuclear (Boston, Mass.) as previously described (8 Six rabbits were injected with estrogen alone (estrogen-primed) by either protocol I or II (Methods).
Six weight-matched rabbits were inijected with estrogen followed by progesterone (progesteroneprimed 2 ,uM) . Thus, the reported decreased alpha adrenergic responsiveness to epinephrine in progesterone-primed uteri is not due to an alteration in the affinity of the sites for epinephrine.
In a single experiment, rabbits were injected by a modification of protocol II in which the dose of estrogen was much lower (0.01 mg/kg) than the dose used in other experiments. At this low dose of estrogen, the estrogen-primed uterine membranes had a threefold higher number of alpha adrenergic receptors than the progesterone-primed uterine membranes. Thus, even at a low dose of estrogen, the alteration in receptor number caused by these steroid hormones is observed. In a separate experiment, the binding of 8 nM [3H]DHE was measured in uterine membranes from immature untreated control rabbits. The level of binding in these membranes was intermediate between the levels of binding in the estrogen-and progesterone-primed uteri, being 1.5-fold the value for the binding observed in progesterone-primed uterine membranes and 46% of the value observed in estrogen-primed uterine membranes.
DISCUSSION
The results of this investigation demonstrate that, as assessed by [3H]DHE binding, the density of alpha adrenergic receptors in this particulate fraction from estrogen-primed rabbit uteri is threefold higher than the density of alpha adrenergic receptors in a similar fraction from progesterone-primed uteri. This result was statistically significant (P < 0.02) in five experiments involving over 60 animals. This alteration in number of alpha adrenergic receptors may represent a Myometrial Alpha Adrenergic Receptors 817 mechanism by which estrogen and progesterone regulate the contractile sensitivity of the myometrium to alpha adrenergic stimulation. Thus, under the influence of progesterone, the number of functional alpha adrenergic receptors would be reduced and the ability of alpha adrenergic stimulation to elicit a contraction would be concomitantly reduced.
The results ofthis study are consistent with previous investigations of the effects of steroid hormones on adrenergic responsiveness of the rabbit uterus. Thus, Miller and Marshall (5) have demonstrated that if rabbits were treated with estrogen, their uteri contracted when the hypogastric nerve was stimulated or when norepinephrine was applied externally, whereas if rabbits were treated with estrogen followed by progesterone administration, their uteri would be inhibited by both nerve stimulation and by application of norepinephrine. Nesheim (6) confirmed and extended these findings by demonstrating that in estrogen-primed longitudinal uterine muscle there was a significantly greater response to alpha adrenergic stimulation than in the progesterone-primed muscle. The changes in the number of [3H]DHE-binding sites observed in the present study parallel the reported changes in alphaadrenergic contractile responsiveness (5, 6) . Previous studies (6) have reported no difference in beta adrenergic responsiveness between estrogen-and progesterone-primed longitudinal uterine muscle. Thus far, attempts in our laboratory to measure uterine beta adrenergic receptors by binding studies using techniques described for beta adrenergic receptor identification with (-) [3H]dihydroalprenolol (11, 13, 14) have not been successful because of high levels of nonspecific binding in the uterus.
The concept of one hormone (e.g. progesterone) regulating the receptors for another hormone (e.g. epinephrine) may apply to a number of biological systems. For example Wolfe et al. (15) have demonstrated that endogenous adrenal steroids regulate the number of hepatic beta adrenergic receptors. Similarly Williams et al. (16) have recently demonstrated that the number of cardiac beta adrenergic receptors can be regulated by thyroid hormone. Hence these regulatory mechanisms may be of general significance in understanding the physiology and pathophysiology of adrenergic responses.
